[MDGL] QoQ Quarter Result on 31-Dec-2019 [#Q4]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
26-Feb-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -29.45%
YoY- -141.74%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -57,963 -49,023 -36,135 -27,740 -21,429 -19,699 -15,080 144.77%
Tax 0 -1,319 0 -28 0 0 0 -
NP -57,963 -49,023 -36,135 -27,740 -21,429 -19,699 -15,080 144.77%
Tax Rate - - - - - - - -
Total Cost 57,963 49,023 36,135 27,740 21,429 19,699 15,080 144.77%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
EPS -3.75 -3.18 -2.34 -1.80 -1.39 -1.28 -0.98 144.04%
EPS Diluted -3.75 -3.18 -2.34 -1.80 -1.39 -1.28 -0.98 144.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.